• Publications
  • Influence
European cardiovascular disease statistics
This is the third edition of European cardiovascular disease statistics, which was the first publication to bring together all the available sources of information about the burden of CVD in Europe, including data on death and illness, treatment, the prevalence of behavioural risk factors for CVD, andThe prevalence of medical conditions associated with CVD.
Economic burden of cardiovascular diseases in the enlarged European Union.
This study is the first to assess the economic burden of CVD across the EU, and the results should help policy makers evaluate policy impact and prioritize research expenditures, but because of data unavailability, this study has important limitations.
Cost of cardiovascular diseases in the United Kingdom
CVD is a leading public health problem in the UK measured by the economic burden of disease, and the size and main components of that burden are identified to inform decisions about research priorities and to monitor the impact of policy initiatives.
Quality of life after TIA and stroke
Quality-adjusted survival is low over the 5 years after stroke and TIA, with severity and recurrent stroke being major predictors, and considerable scope for improvements in acute treatment and secondary prevention to improve the quality of life.
Population-Based Study of Acute- and Long-Term Care Costs after Stroke in Patients with AF
Although annual post acute phase hospital and primary health-care costs in stroke patients with prior atrial fibrillation were not significantly different to those incurred before the stroke, long-term nursing/residential care costs were substantial.
Mapping the Modified Rankin Scale (mRS) Measurement into the Generic EuroQol (EQ-5D) Health Outcome
An algorithm is constructed to translate the modified Rankin scale (mRS) into EQ-5D utility values that can be used with different country-specific tariff valuations and should not replace prospective collection of utility data.